TScan Therapeutics stock is traded under the ticker #TCRX. Below you can review TScan Therapeutics stock performance in the past 12 months up to June 2026

Total visits to TScan Therapeutics's top domains

Understand TScan Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

tscan.com7.8K

See more with Sales Intelligence

Avg. visit duration in TScan Therapeutics's top domains

Analyze TScan Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

tscan.com00:00:31

See more with Sales Intelligence

Avg. pageviews on TScan Therapeutics's top domains

See how TScan Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

tscan.com1.86

See more with Sales Intelligence

TScan Therapeutics top competitors by domain

Top similar sites in June 2026, ranked by their affinity

calliditas.seCompany NameCalliditas Therapeutics ABEmployees51 - 200HQSweden, stockholmAnnual revenue$100M - $200MTotal visits4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by TScan Therapeutics

These are the website technologies, by industry, used by TScan Therapeutics top domains

Widget (8)

Twemoji

Content Management System (4)

WordPress

Marketing (3)

Google Marketing Platform

Social (3)

Instagram

More Technologies

10

See all

News & Signals from TScan Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTScan Therapeutics, Inc. is developing TCR-T therapy candidate for acute myeloid leukemia on Jun 5th '26.Cellares and TScan Therapeutics have agreed to evaluate automated clinical manufacturing of a TCR-T therapy candidate for acute myeloid leukemia.

NewsCellares Corporation partnered with TScan Therapeutics, Inc. on Jun 5th '26.Cellares, TScan partner on automated TSC-101 manufacturing.

NewsTScan Therapeutics, Inc. attended event American Society of Gene and Cell Therapy 29th Annual Meeting on May 11th '26.TScan Therapeutics announces upcoming presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting.